Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol

被引：83
作者：
Garg, Satish K. [1 ,2 ]
Peters, Anne L. [3 ]
Buse, John B. [4 ]
Danne, Thomas [5 ]
机构：
[1] Univ Colorado Denver, Sch Med, Dept Med & Pediat, Aurora, CO USA
[2] Barbara Davis Ctr Diabet, Aurora, CO USA
[3] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[4] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA
[5] Hannover Med Sch, Childrens & Youth Hosp Bult, Hannover, Germany
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2018年 / 20卷 / 09期
关键词：
INSULIN; KETOACIDOSIS; DAPAGLIFLOZIN; CHILDREN; STATE;
D O I：
10.1089/dia.2018.0246
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：571 / 575
页数：5
相关论文
共 27 条
  • [1] [Anonymous], 2017, National Diabetes Statistics Report
  • [2] Basal insulin for the management of diabetic ketoacidosis
    Barski, Leonid
    Brandstaetter, Evgenia
    Sagy, Iftach
    Jotkowitz, Alan
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 47 : 14 - 16
  • [3] Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
    Bonner, Caroline
    Kerr-Conte, Julie
    Gmyr, Valery
    Queniat, Gurvan
    Moerman, Ericka
    Thevenet, Julien
    Beaucamps, Cedric
    Delalleau, Nathalie
    Popescu, Iuliana
    Malaisse, Willy J.
    Sener, Abdullah
    Deprez, Benoit
    Abderrahmani, Amar
    Staels, Bart
    Pattou, Francois
    [J]. NATURE MEDICINE, 2015, 21 (05) : 512 - U139
  • [4] Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
    Buse, John B.
    Garg, Satish K.
    Rosenstock, Julio
    Bailey, Timothy S.
    Banks, Phillip
    Bode, Bruce W.
    Danne, Thomas
    Kushner, Jake A.
    Lane, Wendy S.
    Lapuerta, Pablo
    McGuire, Darren K.
    Peters, Anne L.
    Reed, John
    Sawhney, Sangeeta
    Strumph, Paul
    [J]. DIABETES CARE, 2018, 41 (09) : 1970 - 1980
  • [5] Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
    Dandona, Paresh
    Mathieu, Chantai
    Phillip, Moshe
    Hansen, Lars
    Griffen, Steven C.
    Tschope, Diethelm
    Thoren, Fredrik
    Xu, John
    Langkilde, Anna Maria
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (11) : 864 - 876
  • [6] HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
    Danne, Thomas
    Cariou, Bertrand
    Banks, Phillip
    Brandle, Michael
    Brath, Helmut
    Franek, Edward
    Kushner, Jake A.
    Lapuerta, Pablo
    McGuire, Darren K.
    Peters, Anne L.
    Sawhney, Sangeeta
    Strumph, Paul
    [J]. DIABETES CARE, 2018, 41 (09) : 1981 - 1990
  • [7] Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
    Ferrannini, Ele
    Muscelli, Elza
    Frascerra, Silvia
    Baldi, Simona
    Mari, Andrea
    Heise, Tim
    Broedl, Uli C.
    Woerle, Hans-Juergen
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (02) : 499 - 508
  • [8] Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor
    Fralick, Michael
    Schneeweiss, Sebastian
    Patorno, Elisabetta
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (23) : 2300 - 2302
  • [9] Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes
    Gogtay, Nithya J.
    Bose, Debdipta
    Thatte, Urmila M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (10) : 966 - 966
  • [10] Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
    Garg, Satish K.
    Henry, Robert R.
    Banks, Phillip
    Buse, John B.
    Davies, Melanie J.
    Fulcher, Gregory R.
    Pozzilli, Paolo
    Gesty-Palmer, Diane
    Lapuerta, Pablo
    Simo, Rafael
    Danne, Thomas
    McGuire, Darren K.
    Kushner, Jake A.
    Peters, Anne
    Strumph, Paul
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (24) : 2337 - 2348
123